Biophan Technologies, Inc., a developer of next-generation medical technology, in conjunction with MYOTECH, LLC, recently presented results of animal studies that indicate the potential of the MYO-VAD, a cardiac support system to significantly improve the treatment of heart failure. The MYO-VAD restores cardiac output on an arrested or weak heart. The device can be implanted in approximately three minutes.
Researchers at the University of Illinois at Chicago have taken the dangerous guesswork out of dosing a life-saving medication for congestive heart failure.
The Society for Cardiovascular Angiography and Interventions (SCAI) has released recommendations for the prevention of contrast induced nephropathy (CIN) — potentially fatal kidney damage that can occur when a special dye is injected during certain cardiovascular procedures. The consensus document, the first to be written on this topic, appears in the January 2007 issue of Catheterization and Cardiovascular Interventions: Journal of the Society for Cardiovascular Angiography and Interventions.
At the 2006 American Society for Cell Biology conference, scientists present the first research findings of a system that can pattern the formation of multiiple tissues from a single population of adult stem cells.
This tip sheet provides summaries of the studies published in the November/December issue of Annals of Family Medicine and cover topics such as antibiotic use for rhinosinusitis and sore throat, the impact of the 2004 flu vaccine shortage and other clinical topics.
Georgia Tech and Emory University researchers have developed an innovative new technology that will help pediatric cardiac surgeons design and test a customized surgical procedure before they ever pick up a scalpel.
An implantable pump can help heart-failure patients live and recover strength while they wait for a transplant. But an evaluation concludes that the UK’s National Health Service should continue to restrict the technology’s use — at least for now.
The first large-scale review of weight-loss surgeries performed on older adults suggests bariatric procedures should generally be limited to people younger than age 65, researchers at UT Southwestern Medical Center have found.
A new study shows that blood flow to the legs is relatively normal in people with diastolic heart failure, suggesting other potential causes of their inability to do everyday activities, according to researchers at Wake Forest University Baptist Medical Center.
Stretching out a dose of chemotherapy over six or more hours may reduce the risk of heart problems caused by certain commonly used chemotherapy drugs, according to a new review of recent research.